Oxford Nanopore Technologies (LON:ONT) Shares Down 10.2% – What’s Next?

Oxford Nanopore Technologies plc (LON:ONT) shares fell 10.2% on Monday . The company traded as low as GBX 127 ($1.59) and last traded at GBX 128.50 ($1.61). 3,354,197 shares were traded during trading, an increase of 54% from the average session volume of 2,182,529 shares. The stock had previously closed at GBX 143.10 ($1.79).

Wall Street Analyst Weigh In

A number of analysts have commented on the stock. JPMorgan Chase & Co. reiterated an “overweight” rating on shares of Oxford Nanopore Technologies in a research note on Friday, December 6th. Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a GBX 190 ($2.38) price objective on shares of Oxford Nanopore Technologies in a research note on Wednesday, September 4th. Finally, Berenberg Bank restated a “buy” rating and issued a GBX 282 ($3.54) price target on shares of Oxford Nanopore Technologies in a research note on Tuesday, September 3rd. Five equities research analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus target price of GBX 235.50 ($2.95).

Oxford Nanopore Technologies Trading Up 5.3 %

The company has a market cap of £1.27 billion, a P/E ratio of -676.50 and a beta of 0.80. The company has a quick ratio of 6.01, a current ratio of 4.45 and a debt-to-equity ratio of 8.07. The business has a fifty day moving average price of GBX 142.03 and a 200-day moving average price of GBX 129.81.

Insider Activity at Oxford Nanopore Technologies

In other news, insider Gurdial (Gordon) Sanghera sold 1,993,571 shares of the stock in a transaction on Tuesday, October 15th. The stock was sold at an average price of GBX 142 ($1.78), for a total transaction of £2,830,870.82 ($3,548,791.30). Insiders bought 310 shares of company stock worth $45,010 in the last ninety days. 32.62% of the stock is owned by company insiders.

About Oxford Nanopore Technologies

Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a nanopore based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific.